Table 1 General characteristics of the study patients (n = 34)
From: Potential usefulness of 68Ga-citrate PET/CT in detecting infected lower limb prostheses
Entire cohort (n = 34) | Infected group (n = 26) | Non-infected group (n = 8) | |
|---|---|---|---|
Age, years | 64 (31–86) | 68.5 (31–86) | 66 (44–67) |
Male sex | 19 (55.9%) | 15 (57.7%) | 4 (50%) |
Clinical presentations | |||
Fever | 1 (2.9%) | 1 (3.8%) | 0 (0%) |
Joint pain | 30 (88.2%) | 22 (84.6%) | 8 (100%) |
Joint swelling | 8 (23.5%) | 8 (30.8%) | 0 (0%) |
Local heat | 5 (14.7%) | 5 (19.2%) | 0 (0%) |
Secretion | 5 (14.7%) | 5 (19.2%) | 0 (0%) |
Laboratory findings | |||
C-reactive protein, mg/L | 21.7 (0.2–250.9) | 35.7 (2–250.9) | 1.4 (0.2–3) |
White blood cells, 103/μL | 7.4 (1.8–18.0) | 7.6 (1.8–18.0) | 6.2 (4.4–9.1) |
Erythrocyte sedimentation rate, mm/h | 39 (2–116) | 67 (2–116) | 8 (18.5–36) |
Cause of total joint arthroplasty | |||
Osteoarthritis | 21 (61.8%) | 18 (69.2%) | 3 (37.5%) |
Avascular necrosis | 3 (8.8%) | 2 (7.7%) | 1 (12.5%) |
Trauma | 6 (17.6%) | 4 (15.4%) | 2 (25%) |
Fracture | 3 (8.8%) | 2 (7.7%) | 1 (12.5%) |
Rheumatoid arthritis | 1 (2.9%) | 1 (3.8%) | 0 (0%) |
Prosthesis location, hip | 19 (55.9%) | 12 (46.2%) | 7 (87.5%) |
Prosthesis age, days | 180 (7–6000) | 180 (7–1800) | 135 (58–6000) |